China Pharma Holdings, Inc. is engaged in the development, manufacture and marketing of pharmaceutical products for human uses in connection with a range of high-incidence and high-mortality diseases and medical conditions in the People's Republic of China (the PRC). All of the Company's operations are conducted in the PRC, where its manufacturing facilities are located. The Company manufactures pharmaceutical products in the form of dry powder injectibles, liquid injectibles, tablets, capsules, oral solutions and granules. All of the Company's pharmaceutical products are sold on a prescription basis and have been approved for at least one or more therapeutic indications by the Chinese State Food and Drug Administration (the SFDA). As of December 31, 2011, the Company manufactured 20 pharmaceutical products for a range of diseases and medical indications.